Eastwood Bio-Medical Canada, Inc. (EBM.V)
1.89
-0.05
(-2.58%)
CAD |
TSXV |
Oct 13, 16:00
Eastwood Bio-Medical Canada Net Income (Quarterly) : -0.0676M for July 31, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| July 31, 2026 | -0.0676M |
| April 30, 2026 | -0.0664M |
| January 31, 2026 | -0.0207M |
| October 31, 2025 | -0.0769M |
| July 31, 2025 | -0.0578M |
| April 30, 2025 | -0.1569M |
| January 31, 2025 | -0.0412M |
| October 31, 2024 | -0.1559M |
| July 31, 2024 | -0.1152M |
| April 30, 2024 | -0.1301M |
| January 31, 2024 | -0.0542M |
| October 31, 2023 | -0.1842M |
| July 31, 2023 | -0.1173M |
| April 30, 2023 | -0.1758M |
| January 31, 2023 | -0.0692M |
| October 31, 2022 | -0.025M |
| July 31, 2022 | -0.0853M |
| April 30, 2022 | -0.0293M |
| January 31, 2022 | -0.0103M |
| October 31, 2021 | -0.0054M |
| Date | Value |
|---|---|
| July 31, 2021 | -0.1762M |
| April 30, 2021 | -0.2305M |
| January 31, 2021 | -0.1916M |
| October 31, 2020 | -0.2763M |
| July 31, 2020 | -0.0734M |
| April 30, 2020 | -0.2589M |
| January 31, 2020 | -0.2439M |
| October 31, 2019 | -0.1877M |
| July 31, 2019 | -0.1062M |
| April 30, 2019 | -0.2918M |
| January 31, 2019 | 0.0051M |
| October 31, 2018 | -0.3348M |
| July 31, 2018 | -0.1626M |
| April 30, 2018 | -0.2103M |
| January 31, 2018 | -0.1543M |
| October 31, 2017 | -0.1241M |
| July 31, 2017 | -0.1319M |
| April 30, 2017 | -0.113M |
| January 31, 2017 | -0.1206M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| TransCanna Holdings, Inc. | -- |
| Body & Mind, Inc. | -- |
| Aequus Pharmaceuticals, Inc. | 0.3705M |
| Chartwell Retirement Residences | -1.339M |
| Extendicare, Inc. | 30.85M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.1498M |
| Total Expenses (Quarterly) | 0.2174M |
| EPS Diluted (Quarterly) | -0.001 |
| Enterprise Value | 130.25M |
| Gross Profit Margin (Quarterly) | 47.66% |
| Profit Margin (Quarterly) | -45.13% |
| Earnings Yield | -0.18% |
| Normalized Earnings Yield | -0.1799 |